Valuation — not yet established
No valuation for Patara Pharma is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($31.8M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Patara Pharma
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2018 | Buyout/LBO (Add-on)† | — | ▮ | ▮ |
| Sep 2016 | Early Stage VC | $6.0M | ▮ | ▮ |
| Aug 2014 | Early Stage VC | $24.0M | ▮ | ▮ |
| Jan 2014 | Seed Round | $1.8M | ▮ | ▮ |
How Patara Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Patara Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Patara Pharma raised?
- Patara Pharma has raised $31.8M in total funding across 4 recorded rounds.
- When did Patara Pharma last raise?
- Patara Pharma last raised in Sep 2018 (Buyout/LBO (Add-on)†).